Such an evaluation may provide a more profound understanding of the involvement of these angiogenic proteins in colorectal tumour progression, particularly considering the known differences in binding affinities of VEGF ligands to their receptors. The gene discussed is VEGFA; the disease is colorectal neoplasm.